{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:49:50Z","timestamp":1768783790019,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,20]],"date-time":"2013-07-20T00:00:00Z","timestamp":1374278400000},"content-version":"vor","delay-in-days":992,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.jjcc.2010.08.001","type":"journal-article","created":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T05:21:40Z","timestamp":1285910500000},"page":"262-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["Roles of atrial natriuretic peptide and its therapeutic use"],"prefix":"10.1016","volume":"56","author":[{"given":"Yoshihiko","family":"Saito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2010.08.001_bib0005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0024-3205(83)90390-9","article-title":"Cardionatrin I\u2014a novel heart peptide with potent diuretic and natriuretic properties","volume":"33","author":"de Bold","year":"1983","journal-title":"Life Sci"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0010","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0006-291X(84)91077-5","article-title":"Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP)","volume":"118","author":"Kangawa","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0015","first-page":"907","article-title":"Molecular biology and biochemistry of the natriuretic peptide system. I: natriuretic peptides","volume":"10","author":"Nakao","year":"1992","journal-title":"J Hypertens"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0020","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/00004872-199210000-00002","article-title":"Molecular biology and biochemistry of the natriuretic peptide system. II: natriuretic peptide receptors","volume":"10","author":"Nakao","year":"1992","journal-title":"J Hypertens"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0025","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/01.CIR.0000159340.93220.E4","article-title":"Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure","volume":"111","author":"Sackner-Bernstein","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0030","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10557-009-6167-6","article-title":"Impact of nesiritide on renal function and mortality in patients suffering from heart failure","volume":"23","author":"Dontas","year":"2009","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0035","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jacc.2006.10.048","article-title":"Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: the NAPA Trial","volume":"49","author":"Mentzer","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0040","first-page":"99","article-title":"Electron microscopy of the atrium of the heart","volume":"14","author":"Kisch","year":"1956","journal-title":"Exp Med Surg"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0045","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3181\/00379727-161-40584","article-title":"Heart atria granularity effects of changes in water-electrolyte balance","volume":"161","author":"de Bold","year":"1979","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0050","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/332078a0","article-title":"A new natriuretic peptide in porcine brain","volume":"332","author":"Sudoh","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0055","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0006-291X(90)92401-K","article-title":"C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain","volume":"168","author":"Sudoh","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0060","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0006-291X(89)80056-7","article-title":"Brain natriuretic peptide is a novel cardiac hormone","volume":"158","author":"Saito","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0065","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1172\/JCI115146","article-title":"Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide","volume":"87","author":"Mukoyama","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0070","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1210\/endo-126-4-2225","article-title":"Rat brain natriuretic peptide-Tissue distribution and molecular form","volume":"126","author":"Ogawa","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0075","series-title":"cGMP regulated protein kinases (cGK): a textbook of cGMP: generators, effectors and therapeutic implications","author":"Hofmann","year":"2009"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0080","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/nm958","article-title":"Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure","volume":"9","author":"Tang","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0085","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1172\/JCI23360","article-title":"Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide","volume":"115","author":"Sabrane","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0090","first-page":"777","article-title":"Control of extracellular fluid volume and the pathophysiology of edema formation: a textbook of disturbances in control of body fluid volume and composition","volume":"vol. 1","author":"Abassi","year":"1999"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0095","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1126\/science.7839143","article-title":"Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension","volume":"267","author":"John","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/378065a0","article-title":"Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide","volume":"378","author":"Lopez","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0105","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1161\/01.CIR.0000029923.57048.61","article-title":"Guanylyl cyclase-A inhibits angiotensin II type 2 receptor-mediated pro-hypertrophic signaling in the heart","volume":"106","author":"Li","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0110","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1172\/JCI17061","article-title":"Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A","volume":"111","author":"Holtwick","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0115","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1161\/CIRCULATIONAHA.107.732990","article-title":"Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart","volume":"117","author":"Tokudome","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0120","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1291\/hypres.31.1251","article-title":"The specific mineralocorticoid receptor blocker eplerenone attenuates left ventricular remodeling in mice lacking the gene encoding guanylyl cyclase-A","volume":"31","author":"Zhang","year":"2008","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0125","doi-asserted-by":"crossref","first-page":"7142","DOI":"10.1073\/pnas.102650499","article-title":"Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure","volume":"99","author":"Holtwick","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0130","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1210\/en.2008-1360","article-title":"Chronic endothelium-dependent regulation of arterial blood pressure by atrial natriuretic peptide: role of nitric oxide and endothelin-1","volume":"150","author":"Sabrane","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0135","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/01.CIR.88.1.82","article-title":"Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction","volume":"88","author":"Morita","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0140","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1071-9164(97)90028-2","article-title":"Effects of angiotensin-converting enzyme inhibitor on plasma B-type natriuretic peptide levels in patients with acute myocardial infarction","volume":"3","author":"Mizuno","year":"1997","journal-title":"J Card Fail"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0145","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/01.HYP.0000173420.31354.ef","article-title":"Role of natriuretic peptide receptor guanylyl cyclase-A in myocardial infarction evaluated using genetically engineered mice","volume":"46","author":"Nakanishi","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0150","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1172\/JCI12088","article-title":"Blockade of the natriuretic peptide receptor guanylyl cyclase-A inhibits NF-kappaB activation and alleviates myocardial ischemia\/reperfusion injury","volume":"108","author":"Izumi","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0155","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1161\/01.CIR.0000147829.78357.C5","article-title":"Overexpression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase-9 expression after acute myocardial infarction","volume":"110","author":"Kawakami","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0160","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1681\/ASN.V1191691","article-title":"Ameliorated glomerular injury in mice overexpressing brain natriuretic peptide with renal ablation","volume":"11","author":"Kasahara","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0165","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1681\/ASN.V12122652","article-title":"Overexpression of brain natriuretic peptide in mice ameliorates immune-mediated renal injury","volume":"12","author":"Suganami","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0170","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1007\/s00125-006-0352-y","article-title":"Transgenic overexpression of brain natriuretic peptide prevents the progression of diabetic nephropathy in mice","volume":"49","author":"Makino","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0175","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1161\/ATVBAHA.109.187526","article-title":"Impaired recovery of blood flow after hind-limb ischemia in mice lacking guanylyl cyclase-A, a receptor for atrial and brain natriuretic peptides","volume":"29","author":"Tokudome","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0180","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1172\/JCI37430","article-title":"The natriuretic peptide\/guanylyl cyclase\u2014a system functions as a stress-responsive regulator of angiogenesis in mice","volume":"119","author":"Kuhn","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0185","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1073\/pnas.0538059100","article-title":"Significance and therapeutic potential of the natriuretic peptides\/cGMP\/cGMP-dependent protein kinase pathway in vascular regeneration","volume":"100","author":"Yamahara","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0190","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1161\/01.CIR.76.1.115","article-title":"Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function","volume":"76","author":"Saito","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0195","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1172\/JCI112723","article-title":"Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion","volume":"78","author":"Cody","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0200","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0140-6736(86)92675-9","article-title":"Haemodynamic effects of atrial peptide infusion in heart failure","volume":"2","author":"Crozier","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0205","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1253\/circj.69.283","article-title":"Multicenter prospective investigation on efficacy and safety of carperitide for acute heart failure in the \u2018real world\u2019 of therapy","volume":"69","author":"Suwa","year":"2005","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0210","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1253\/circj.CJ-07-0760","volume":"72","author":"Nomura","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0215","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1253\/circj.CJ-08-0130","article-title":"Effects of carperitide on the long-term prognosis of patients with acute decompensated chronic heart failure: the PROTECT multicenter randomized controlled study","volume":"72","author":"Hata","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0220","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/01.fjc.0000177980.83810.2e","article-title":"Inhibition of aldosterone and endothelin-1 by carperitide was attenuated with more than 1 week of infusion in patients with congestive heart failure","volume":"46","author":"Ishikawa","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0225","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1253\/circj.71.1040","article-title":"Predominant effect of A-type natriuretic peptide on reduction of oxidative stress during the treatment of patients with heart failure","volume":"71","author":"Shono","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0230","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/S0735-1097(01)01233-5","article-title":"Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction","volume":"37","author":"Hayashi","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0235","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0140-6736(07)61634-1","article-title":"Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials","volume":"370","author":"Kitakaze","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0240","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0003-4975(99)01305-3","article-title":"Low-dose continuous infusion of human atrial natriuretic peptide during and after cardiac surgery","volume":"69","author":"Sezai","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0245","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jacc.2008.10.061","article-title":"Renal protective effects and the prevention of contrast-induced nephropathy by atrial natriuretic peptide","volume":"53","author":"Morikawa","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2010.08.001_bib0250","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00228-007-0309-1","article-title":"ANP is cleared much faster than BNP in patients with congestive heart failure","volume":"63","author":"Kimura","year":"2007","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508710001449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508710001449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:48:18Z","timestamp":1760273298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508710001449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0914508710001449"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2010.08.001","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Roles of atrial natriuretic peptide and its therapeutic use","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2010.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}